Abstract:Stomatin-like protein 2 (STOML2), a member of the stomatin, has been reported to be upregulated in several human cancers. However, its role and clinical significance in gastric adenocarcinoma remains unclear to date. The purpose of this retrospective study was to explore whether there was a correlation between the expression of STOML2 by immunohistochemistry and the clinical outcome of a large group of patients with gastric adenocarcinoma. In this retrospective study, we performed immunohistochemistry to evaluation of STOML2 expression in a large panel of gastric adenocarcinoma samples. The receiver operating characteristic method was used to define the STOML2 immunoreactivity score cutoff value. The clinical/prognostic significance of STOML2 expression was analyzed statistically. Kaplan-Meier analysis was used to compare the postoperative survival between groups. STOML2 was overexpressed in gastric cancer compared with paracancerous normal mucosa. Increased STOML2 expression was associated with higher histologic grade (P = 0.047), T category (P < 0.001), and N category (P = 0.01). Patients with high expression of STOML2 demonstrated shortened overall survival compared with those with low expression of STOML2 (median of 38.9 vs. 64.0 months, P < 0.001). Furthermore, STOML2 expression could stratify patients survival in stage N0 (P < 0.001). Multivariate analysis showed that the level of STOML2 expression was an independent prognostic factor in gastric adenocarcinoma (RR = 1.920, P = 0.001). Increased expression of STOML2 suggests unfavorable prognosis for gastric adenocarcinoma patients. Further studies are warranted.

Supplementary Figure 1 from Stomatin-like Protein 2 is Overexpressed in Cancer and Involved in Regulating Cell Growth and Cell Adhesion in Human Esophageal Squamous Cell Carcinoma

[Effect of Stomatin-Like Protein 2 (SLP-2) Gene on Growth and Proliferation of Esophageal Squamous Carcinoma Cell Line TE12].

Supplementary Figure 2 from Amplification and Overexpression of <i>cttn</i> (<i>ems1</i>) Contribute to the Metastasis of Esophageal Squamous Cell Carcinoma by Promoting Cell Migration and Anoikis Resistance

Figure S2 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Figure S4 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Supplementary Figure 3 from Amplification and Overexpression of <i>CTTN</i> (<i>EMS1</i>) Contribute to the Metastasis of Esophageal Squamous Cell Carcinoma by Promoting Cell Migration and Anoikis Resistance

Figure S3 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Supplementary Figure 2 from Api6/AIM/Spα/CD5L Overexpression in Alveolar Type II Epithelial Cells Induces Spontaneous Lung Adenocarcinoma

Supplementary Tables 1-2, Figure 1 from HOXA13 Promotes Cancer Cell Growth and Predicts Poor Survival of Patients with Esophageal Squamous Cell Carcinoma

Increased Expression of Stomatin-Like Protein 2 (STOML2) Predicts Decreased Survival in Gastric Adenocarcinoma: a Retrospective Study

Supplementary Figure 2 from DACT2 is a Candidate Tumor Suppressor and Prognostic Marker in Esophageal Squamous Cell Carcinoma

Supplementary Figure Legends 1-3 from Amplification and Overexpression of <i>cttn</i> (<i>ems1</i>) Contribute to the Metastasis of Esophageal Squamous Cell Carcinoma by Promoting Cell Migration and Anoikis Resistance

Coexisting Overexpression of STOML1 and STOML2 Proteins May Be Associated with Pathology of Oral Squamous Cell Carcinoma.

Supplementary Data from Suppression of Anoikis by <i>skp2</i> Amplification and Overexpression Promotes Metastasis of Esophageal Squamous Cell Carcinoma

Supplementary Information from Downregulation of MicroRNA-644a Promotes Esophageal Squamous Cell Carcinoma Aggressiveness and Stem Cell–like Phenotype Via Dysregulation of PITX2

Suppl Figure 1 from FSTL1 Promotes Metastasis and Chemoresistance in Esophageal Squamous Cell Carcinoma Through NFκB–BMP Signaling Cross-talk

Supplementary Figures 1-2 from Bile Acid Reflux Contributes to Development of Esophageal Adenocarcinoma Via Activation of Phosphatidylinositol-Specific Phospholipase Cγ2 and NADPH Oxidase NOX5-S

Overexpression Of Stefin A In Human Esophageal Squamous Cell Carcinoma Cells Inhibits Tumor Cell Growth, Angiogenesis, Invasion, And Metastasis

Suppl Figure Legends and Tables from FSTL1 Promotes Metastasis and Chemoresistance in Esophageal Squamous Cell Carcinoma Through NFκB–BMP Signaling Cross-talk

Supplementary Figure 2 from EphB3 Is Overexpressed in Non–Small-Cell Lung Cancer and Promotes Tumor Metastasis by Enhancing Cell Survival and Migration